Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023

Each year, the American Association for Cancer Research (AACR) publishes an annual report to Congress and the American public highlighting how biomedical research extends and improves lives by accelerating advances in cancer prevention, detection, diagnosis, and treatment. Over the past decade, immunotherapy has become an increasingly central component of the report as the number of immunotherapies approved by the FDA has grown. The incredible progress that has been made in using immunotherapy for the benefit of patients with cancer is celebrated in the latest edition of the report—AACR Cancer Progress Report 2023 (freely available at https://cancerprogressreport.aacr.org/progress/)—with a dedicated section titled, “Immunotherapy: Pushing the Frontier of Cancer Medicine.” As part of that special feature, we provide a perspective on the advances that have been made in the use of immune checkpoint therapy (ICT) and on the approaches that we believe will bring more breakthroughs in ICT, in the form...